Mike Householder / AP Roger Pontz wears special glasses that house a small video camera and wirelessly transmit images, converted into a series of electrical pulses, to an array of electrodes on the surface of his retna. The pulses stimulate the retinas remaining healthy cells, causing them to relay the data to the optic nerve. A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure that involved the surgical implantation of a "bionic eye," he's regained enough of his eyesight to catch small glimpses of his wife, grandson and cat. "It's awesome. It's exciting seeing something new every day," Pontz said during a recent appointment at the University of Michigan Kellogg Eye Center. The 55-year-old former competitive weightlifter and factory worker is one of four people in the U.S. to receive an artificial retina since the Food and Drug Administration signed off on its use last year. The facility in Ann Arbor has been the site of all four such surgeries since FDA approval. A fifth is scheduled for next month. Retinitis pigmentosa is an inherited disease that … Continue reading →

By MIKE HOUSEHOLDER Associated Press ANN ARBOR, Mich. (AP) - A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure that involved the surgical implantation of a "bionic eye," he has regained enough of his eyesight to catch small glimpses of his wife, grandson and cat. "It's awesome. It's exciting - seeing something new every day," Pontz said during a recent appointment at the University of Michigan Kellogg Eye Center. The 55-year-old former competitive weightlifter and factory worker is one of four people in the U.S. to receive an artificial retina since the Food and Drug Administration signed off on its use last year. The facility in Ann Arbor has been the site of all four such surgeries since FDA approval. A fifth is scheduled for next month. Retinitis pigmentosa is an inherited disease that causes slow but progressive vision loss due to a gradual loss of the light-sensitive retinal cells called rods and cones. Patients experience loss of side vision and night vision, then central vision, which can result in near blindness. Not all of the 100,000 … Continue reading →

ANN ARBOR, MICH.A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure that involved the surgical implantation of a bionic eye, hes regained enough of his eyesight to catch small glimpses of his wife, grandson and cat. Its awesome. Its exciting seeing something new every day, Pontz said during a recent appointment at the University of Michigan Kellogg Eye Center. The 55-year-old former competitive weightlifter and factory worker is one of four people in the U.S. to receive an artificial retina since the Food and Drug Administration signed off on its use last year. The facility in Ann Arbor has been the site of all four such surgeries since FDA approval. A fifth is scheduled for next month. Retinitis pigmentosa is an inherited disease that causes slow but progressive vision loss due to a gradual loss of the light-sensitive retinal cells called rods and cones. Patients experience loss of side vision and night vision, then central vision, which can result in near blindness. Not all of the 100,000 or so people in the U.S. with retinitis pigmentosa can … Continue reading →